[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100323559":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":30,"responsibleParty":47,"collaborators":11,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":11,"enrollmentInfo":58,"targetDuration":11,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":11,"overallStatus":33,"whyStopped":11,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Assistance Publique Hopitaux De Marseille","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Cardiovascular patients treated for a cancer","EXPERIMENTAL",null,[13],"Biological: blood samples",[15],{"type":16,"name":17,"description":17,"armGroupLabels":18,"otherNames":11},"BIOLOGICAL","blood samples",[9],[20],{"name":21,"affiliation":22,"role":23},"jean-olivier ARNAUD","Assistance Publique-Hôpitaux de Marseille","STUDY_DIRECTOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":11,"email":29},"franck thuny","CONTACT","33(0)4 91 96 86 83","franck.thuny@ap-hm.fr",[31],{"facility":32,"status":33,"city":34,"state":11,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Assiatnce Publique Hopitaux de Marseille","RECRUITING","Marseille","13354","France","FR",{"type":39,"coordinates":40},"Point",[41,42],5.38107,43.29695,{"lat":42,"lon":41},[45],{"name":46,"role":27,"phone":11,"phoneExt":11,"email":29},"FRANCK THUNY",{"type":48,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100323559","cardiovascular-outcome-of-cancer-patients-the-gmedico-cohort-100323559",false,"NCT03492528","Cardiovascular Outcome of Cancer Patients: The \"GMEDICO Cohort\"","GMEDICO","Inclusion Criteria:\n\n* All adults referred for specialist cardio-oncology consultations before the initiation of a cancer treatment according to pre-established indications will be eligible.\n\nExclusion Criteria:\n\n* Failure to provide information that makes it impossible to complete a consultation form or refuse to sign the consent.\n* Minor or major patient under guardianship\n* Pregnant or breastfeeding woman","ALL","18 Years",{"count":59,"type":60},530,"ESTIMATED","INTERVENTIONAL",[63],"NA","The Mediterranean Group of Cardio-Oncology (GMEDICO) brings together French cardiologists and oncologists who have developed a protocol for the monitoring and cardio-oncological management of patients treated for cancer.\n\nThis unique organization makes it possible to envisage the creation of a large cohort from which the incidence and predictive factors of cardiovascular toxicity can be determined.\n\nPrimary objective: to determine the cardiovascular prognosis of patients treated for cancer and followed up in cardio-oncology.\n\nSecondary objectives\n\n* To determine the clinical, biological and imaging factors associated with cardiovascular events under cancer treatment, in order to define a risk score including clinical, biological (biomarker) and imaging data.\n* To create a biological source for testing other biomarkers and conducting genome-wide association studies and genetic factors associated with cardiovascular events under cancer treatment.",[66],"Cardiovascular Prognosis","2022-09-19",{"date":69,"type":70},"2022-09-21","ACTUAL",{"date":72,"type":70},"2019-07-05",{"date":74,"type":60},"2027-10",{"name":5,"class":6},1]